Disordered haematopoiesis and athero-thrombosis.

This research suggests that in addition to traditional approaches of low-density lipoproteins lowering and anti-platelet drugs, therapies directed at abnormal haematopoiesis, including anti-inflammatory agents, drugs that suppress myelopoiedis, and excessive platelet production, may help to prevent athero-thrombosis.